These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4369871)

  • 21. Collagen synthesis in keloid and hypertrophic scar following intralesional use of triamcinolone.
    Cohen IK; Keiser HR
    Surg Forum; 1973; 24():521-23. PubMed ID: 4377040
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathologic scar formation. Morphologic and biochemical correlates.
    Knapp TR; Daniels RJ; Kaplan EN
    Am J Pathol; 1977 Jan; 86(1):47-70. PubMed ID: 12661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between angiogenesis and expression of HO-1 of scar].
    Zhu J; Luo CQ; He QY; Peng H; Zhou JD; Li P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):335-9. PubMed ID: 16045028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hexose sugars differentially alter collagen gene expression and synthesis in fibroblasts derived from granulation tissue, hypertrophic scar and keloid.
    Kössi J; Vähä-Kreula M; Peltonen J; Risteli J; Laato M
    Arch Dermatol Res; 2004 May; 295(12):521-6. PubMed ID: 15045512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures.
    Tuan TL; Wu H; Huang EY; Chong SS; Laug W; Messadi D; Kelly P; Le A
    Am J Pathol; 2003 May; 162(5):1579-89. PubMed ID: 12707042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue.
    Arakawa M; Hatamochi A; Mori Y; Mori K; Ueki H; Moriguchi T
    Br J Dermatol; 1996 May; 134(5):863-8. PubMed ID: 8736326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
    Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
    Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crosslink of collagen in hypertrophic scar.
    Moriguchi T; Fujimoto D
    J Invest Dermatol; 1979 Mar; 72(3):143-5. PubMed ID: 422877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of the expression of heat shock protein 47 and its correlation to collagen].
    Chen J; Cen Y; Xu X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jan; 19(1):31-4. PubMed ID: 15704838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation.
    Hsu YC; Hsiao M; Wang LF; Chien YW; Lee WR
    Nitric Oxide; 2006 Jun; 14(4):327-34. PubMed ID: 16517189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
    Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
    Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue alpha-globulins in keloid formation.
    Diegelmann RF; Bryant CP; Cohen IK
    Plast Reconstr Surg; 1977 Mar; 59(3):418-23. PubMed ID: 65777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and significance of mRNA and protein of eIF4E, p-eIF4E and MCl-1 in pathological scar].
    Wu WY; Zhang LT; Zheng ZF; Zhu SZ; Wang ZY
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 Sep; 28(5):360-5. PubMed ID: 23259313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
    Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
    Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Collagen metabolism in hypertrophic and keloid scars].
    Del'vig AA
    Vestn Ross Akad Med Nauk; 1995; (12):41-5. PubMed ID: 8664602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different metabolism of hexose sugars and sucrose in wound fluid and in fibroblast cultures derived from granulation tissue, hypertrophic scar and keloid.
    Kössi J; Laato M
    Pathobiology; 2000; 68(1):29-35. PubMed ID: 10859528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment methods of keloid and hypertrophic scar formation].
    Wester JU; Pilegaard J; Hahn T
    Ugeskr Laeger; 1989 Jan; 151(4):223-5. PubMed ID: 2916252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of mast cell tryptase in scar].
    Gao F; Zhao Y; Feng YQ; Huo R; Xue WJ; Wang FG; Lv RR; Xue F; Li Q; Zhang J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 Mar; 26(2):132-5. PubMed ID: 20540319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunolocalization of collagenase and tissue inhibitor of metalloproteinases (TIMP) in hypertrophic scar tissue.
    Hembry RM; Ehrlich HP
    Br J Dermatol; 1986 Oct; 115(4):409-20. PubMed ID: 3022783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.